Identity
- Trade Name
- IMMUNO CONCEPTS RELISA® Test Systems FDA UDI
- Generic Name
- Immunohistochemistry wash buffer reagent IVD FDA UDI
- Device Name
- RELISA® Wash Buffer Concentrate - 4 x 10ml FDA UDI
- Model / Reference
- 1031 (4) FDA UDI
- Description
- RELISA® Wash Buffer Concentrate - 4 x 10ml FDA UDI
Identifiers
- Catalog Number
- 1031 (4) FDA UDI
- Primary DI / UDI-DI
- M7490103141 FDA UDI
- GMDN Term
- Immunohistochemistry wash buffer reagent IVD FDA UDI
Classification
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
Yes
FDA UDI
Category: Immunohistochemistry wash buffer reagent IVD
IMMUNO CONCEPTS RELISA® Test Systems by Immuno Concepts Inc — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Immunohistochemistry wash buffer reagent IVD.
- Automation Tween 20, 20X — BIOCARE MEDICAL, LLC · Class I
- Immunocare PBS 10X — BIOCARE MEDICAL, LLC · Class I
- IHC — Slmp, LLC · Class I
- TBSplus 10X — BIOCARE MEDICAL, LLC · Class I
- Immunocare TBS Wash Buffer 10X — BIOCARE MEDICAL, LLC · Class I
- 20% Tween 20 — BIOCARE MEDICAL, LLC · Class I
- IHC — Slmp, LLC · Class I
- PBS Plus 10X — BIOCARE MEDICAL, LLC · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | N/A | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Immuno Concepts Inc
Sources (1)
- FDA UDI 11847093-1f9e-4b07-902b-2d31ef240d84 34 fields · synced May 30, 2026